Salvianolic Acid A, a Novel Matrix Metalloproteinase-9 Inhibitor, Reduces Microvascular Damage Induced by Hypertension
Fukang Teng,Yanping Deng,Dengfang Li,Li Zhang,Tingting Zhang,Jun Yin,Baohong Jiang,De-an Guo
DOI: https://doi.org/10.1016/j.eujim.2014.09.100
IF: 1.813
2014-01-01
European Journal of Integrative Medicine
Abstract:s / European Journal of Integrative Medicine 6 (2014) 686–745 731 Salvianolic acid A, a novel matrix metalloproteinase-9 inhibitor, reduces microvascular damage induced by hypertension Fukang Teng, Yanping Deng, Dengfang Li, Li Zhang, Tingting Zhang, Jun Yin, Baohong Jiang, De-an Guo ∗ Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China E-mail address: daguo@simm.ac.cn (D.-a. Guo). Introduction: Despite plenty of pharmacological agents available for hypertension therapy, hypertension-related damage to themicrovascular remodeling is not resolved. The present work aimed to investigate the protection of Salvianolic acid A (SalA), a novel matrix metalloproteinase-9 inhibitor, against microvascular remodeling induced by hypertension. Methods: Spontaneously hypertensive rats (SHR) were administered with 2.5, 5 or 10mg/kg SalA by intraperitoneal injection once a day for 4 weeks. Tail-cuff method was applied to measure blood pressure; microvascular structure of kidney and retina was detected by hematoxylin-eosin and/or immunohistochemical staining; collagen deposition around cardiac microvessels was determined by picric sirius red staining; isometric tensions of small mesenteric arteries were measured by DMTwiremyograph. SalA attenuated themicrovascular inward remodeling on retina and kidney, protected against collagen deposition around cardiac microvessels. Results: Besides the detection on microvascular structure, the improvement of SalA on microvascular vasodilatation was also confirmed based on wire myograph. Even though SalA had significant protection on microvessels, no antihypertensive effect of SalA was found. Conclusions: These results proved that SalA, a novel matrixmetalloproteinase-9 inhibitor, holds significant therapeutic potential for microvascular damage induced by hypertension. http://dx.doi.org/10.1016/j.eujim.2014.09.100 Fangchinoline targets proteasome 1 subunit to exert its anti-cancer effects Dong Li, Xiaobo Qu, Xuan Liu, Dean Guo ∗ Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China E-mail address: daguo@simm.ac.cn (D. Guo). Introduction: In our study screening natural proteasome inhibitors with compounds isolated from traditional Chinese medicines, fangchinoline, a bisbenzylisoquinoline alkaloid isolated from Radix Stephaniae tetrandrae S. Moore (known as Fangji in China), were identified as potent inhibitors for C-L activity of cellular proteasome in PC-3 prostate cancer cells. Fangji is a traditional Chinese medicine used for long time as an antirheumatic, anti-inflammatory and anticancer agent. In the present study, we characterized the inhibiting effects of fangchinoline on proteasome and the involvement of proteasome inhibition in its anti-tumor effects. Methods: The enzymatic activities of cellular proteasome in cell lysate were measured as reported in our previous paper. Fangchinoline dose-dependently inhibit the catalytic activities, especially the caspase-like activity mediated by catalytic 1 subunit, of cellular proteasome. The binding affinities of fangchinoline to recombinant proteasome catalytic subunits, 1, 2 and 5 subunit, were assayed in vitro using a SPR-based Biacore 3000 instrument as reported before. Results: Fangchinoline showed direct binding affinity with recombinant proteasome 1 subunit and also inhibited its enzyme activity in vitro. Inhibition of the proteasome activity by fangchinoline in PC-3 cells resulted in accumulation of ubiquitinated proteins including important proteasome substrates accompanied by cell cycle arrest at G0/G1 phase and apoptosis. Treatment of PC-3 tumor-bearing nude mice with fangchinoline inhibited tumor growth, induced apoptosis and also caused decrease in proteasome activities in tumor xenografts and accumulation of proteasome substrates. Conclusions: In conclusion, fangchinoline exhibited proteasome activity through direct binding with 1 subunit. Proteasome inhibition induced by fangchinoline contributed to its anti-cancer effects. http://dx.doi.org/10.1016/j.eujim.2014.09.101 Anti-cancer activities of BF211, a derivative of bufalin Lixing Feng, Lihong Hu, Xuan Liu, Dean Guo ∗ Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China E-mail address: daguo@simm.ac.cn (D. Guo). Introduction: Epidemiological data as well as in vitro and in vivo studies indicated that cardiac glycosides have anti-cancer activities and also emphasize the possibility of developing this class of compound as anti-cancer agents. Promising compounds such as Anvirzel and UNBS1450 are now in clinical trials in USA and Belgium, respectively. In China, Chansu, a traditional medicine containing bufadienolides, has long been used for treatment of cancer. Among the bufadienolides, bufalin appears to be the most active. However, its narrow therapeutic window limits its therapeutic application. Methods: To find possible new drug candidates for cancer therapy,BF211, a derivative of bufalin,was designed and synthesized. The patent protection for the preparation and anti-tumor usage of BF211 had been authorized (CN 102532235B). Results: Compared with bufalin, BF211 exhibited stronger anti-tumor activity and lower toxicity. The IC50 values of bufalin and BF211 in inhibiting the proliferation of human A549 lung carcinoma cells (72 h treatment) are 8.74± 2.52 and 0.77± 0.28 nM, respectively. The LD50 values of bufalin and BF211 inmice (i.p.) are 2.20 and 14.75mg/kg formalemice and 2.64 and 18.21mg/kg for female mice, respectively. BF211 at 2, 732 Abstracts / European Journal of Integrative Medicine 6 (2014) 686–745 4 and 6mg/kg doses (i.p.) exhibited dose-dependent anti-cancer effects in nude mice innoculating with A549 cells. The binding affinities of BF211 to the alpha subunits of Na,K-ATPase and the inhibiting effects of BF211 on the activity of Na,K-ATPase were similar to that of bufalin. Both bufalin and BF211 could activate caspases and induce apoptosis of A549 cells. There was difference in the regulation of phosphorylation of Src kinase by bufalin or BF211. Conclusion: These results suggest an important role for Src kinase in the anti-cancer mechanism of cardiac glycosides. http://dx.doi.org/10.1016/j.eujim.2014.09.102 Therapeutic effects of Benincasa hispida seed extracts on chronic bacterial prostatitis models in rats Jing Liu , Pinglin Li , Jie Yan , Bin Li , Xuli Tang , Guoqiang Li 1,∗ 1 Key Laboratory of Marine Drugs, Chinese Ministry of Education, School of Medicine and Pharmacy, Ocean University of China, Qingdao 266003, China 2 Dezhou Institute for Drug Control, Dezhou 253000, China 3 Dezhou People’s Hospital, Dezhou 253000, China 4 College of Chemistry and Chemical Engineering, Ocean University of China, Qingdao 266100, PR China E-mail address: liguoqiang@ouc.edu.cn (G. Li). Introduction: The effects of three different extracts of B. hispida seeds including water extract (WE), methanol extract (ME), and petroleum extract (PE) in a rat model of CBP, and the underlying mechanisms were studied in this research. Methods: Six randomly divided groups of male Sprague–Dawley rats including control, model, ciprofloxacin, AE, ME and PE groups were studied. Morphological changes of prostate and histopathological analyses were conducted, and the changes of several CBP-related factors including TNF, IL-6, ICAM-1, SOD, and MDA in the prostate were analyzed. Results: All three extracts displayed significant therapeutic efficacy with ME being the best comparable to antibiotic ciprofloxacin. The therapeutic effect was suggested to be by down-regulating the pro-inflammatory TNF, IL-6 and intercellular adhesion molecule ICAM-1, as well as up-regulating SOD level. Conclusions: The result provides a potential therapeutic agent for CBP disease, especially for patients with antibiotic resistance. Acknowledgements: Hi-tech Research and Development Program of China (No. 2013AA093002). http://dx.doi.org/10.1016/j.eujim.2014.09.103 Toxic and detoxic principles of compatibility of Euphorbia kansui and Zizyphus jujuba in vitro and in vivo Yu-Mei Liu , Cui-Cui He , Rong-Rong Hui , Yue Huai , Jin-Ao Duan , Yu-Ping Tang , Jian-Xin Li 1,∗ 1 State Key Lab of Analytical Chemistry for Life Science, School of Chemistry and Chemical Engineering, Nanjing University, Nanjing 210093, China 2 Jiangsu Key Lab of TCM Formulae Research, Nanjing University of Chinese Medicine, Nanjing 210046, China E-mail address: lijxnju@nju.edu.cn (J.-X. Li). Introduction: The roots of Euphorbia kansui (EK) and the fruits of Zizyphus jujuba (ZJ) have been clinically used in traditional Chinese medicine (TCM) for a long time. This work is to clarify the toxic and detoxic principles that are responsible for the compatibility of EK and ZJ. Methods: The water extracts of EK and ZJ were partitioned. The primary rat hepatocytes, SD rats and NMR-based metabonomic approach were applied for toxicity assay. Results:Assays in vitro revealed that EK2was the toxic principle of EK and ZJ2 exerted detox actions. In vivo studies in rats showed that EK2 possessed liver and kidney toxicities, disturbed gut microbial activities, while, ZJ2 not only relieved the EK2induced toxicity, but also made the toxicity appear ahead in the experiment period Conclusions: EK2 had some accumulative hepatotoxicity, nephrotoxicity and resulted in an imbalance of gut microbial activities. ZJ2 not only lowered EK2-induced toxicity, but also disintegrated the toxic accumulation of EK2. The results proved the excellence of the compatibility of EK and ZJ. Acknowledgements: The study was supported by National Natural Science Fund for Creative Research Groups of China (21121091) and 973 Program (2011CB505300-03). http://dx.doi.org/10.1016/j.eujim.2014.09.104